Johns Hopkins ABX Guide
Gemifloxacin
Gemifloxacin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Currently not available in the U.S. due to legal dispute related to license to manufacture and distribute (FDA notice-Gemifloxacin )
- Community acquired pneumonia (CAP) caused by S. pneumoniae (including multi-drug resistant strains), H. influenzae, M. catarrhalis, M. pneumoniae, C. pneumoniae, or K. pneumoniae
- Acute bacterial exacerbation of chronic bronchitis (AECB) caused by S. pneumoniae, H. influenzae, H. parainfluenzae, or M. catarrhalis
- Use for AECB should be avoided due recent FDA warning (Black Box warning) regarding serious and potentially permanent side effects (tendonitis and tendon rupture, peripheral neuropathy, and CNS side effects). See FDA safety warning regarding fluoroquinolone use.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Currently not available in the U.S. due to legal dispute related to license to manufacture and distribute (FDA notice-Gemifloxacin )
- Community acquired pneumonia (CAP) caused by S. pneumoniae (including multi-drug resistant strains), H. influenzae, M. catarrhalis, M. pneumoniae, C. pneumoniae, or K. pneumoniae
- Acute bacterial exacerbation of chronic bronchitis (AECB) caused by S. pneumoniae, H. influenzae, H. parainfluenzae, or M. catarrhalis
- Use for AECB should be avoided due recent FDA warning (Black Box warning) regarding serious and potentially permanent side effects (tendonitis and tendon rupture, peripheral neuropathy, and CNS side effects). See FDA safety warning regarding fluoroquinolone use.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 5, 2018
Citation
Avdic, Edina. "Gemifloxacin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540241/all/Gemifloxacin.
Avdic E. Gemifloxacin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540241/all/Gemifloxacin. Accessed March 26, 2023.
Avdic, E. (2018). Gemifloxacin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540241/all/Gemifloxacin
Avdic E. Gemifloxacin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2023 March 26]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540241/all/Gemifloxacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Gemifloxacin
ID - 540241
A1 - Avdic,Edina,Pharm.D.
Y1 - 2018/06/05/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540241/all/Gemifloxacin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
